QOF rewards practices for finding the right patients, doing the right clinical work and recording it accurately. That sounds simple, but the achievement gap between practices rarely comes down to clinical skill. It comes down to whether someone is reliably running the searches, keeping disease registers clean, chasing the recalls and coding the outcomes before the year ends. A lot of that work is medicines-related, which is exactly where a QOF clinical pharmacist earns their keep.
This post looks at the practical mechanics of how clinical pharmacists drive QOF achievement, and how a managed clinical pharmacy service keeps that activity coordinated across a whole year rather than leaving it to a March scramble.
Why QOF depends on continuous, coordinated work
QOF is not a single annual task. It is a year-long cycle of identifying eligible patients, inviting them, completing reviews and monitoring, and then recording the result with the correct codes. Each disease area has its own register logic and its own data quality traps. When that cycle runs steadily from April, the work is calm and patients get reviewed properly. When it is left until the final quarter, practices end up booking floods of appointments, missing patients who are hard to reach, and accepting exception coding they could have avoided.
Clinical pharmacists are well placed to own large parts of this cycle because so many indicators hinge on medication. Medicines work can support relevant QOF indicators in areas such as cardiovascular, diabetes and respiratory care. For 2026/27, anticoagulation contributes to AF008 where its criteria are met. Lithium and DMARD monitoring remain important medicines-safety work outside the current QOF indicators. A pharmacist can review the patient, optimise the treatment and make sure the record reflects what was done, in one connected piece of work.
Disease registers: the foundation everything else sits on
Achievement starts with accurate registers. If a patient with hypertension or diabetes is not on the register, the practice gets no credit for managing them and, more importantly, the patient may slip through the net clinically. Registers drift over time as diagnoses are entered inconsistently, codes change, and patients move in and out of the practice.
Pharmacists routinely tidy this up by:
- Identifying patients whose medicines or records suggest a possible missing diagnosis, then asking an appropriately qualified clinician to confirm the diagnosis and coding before changing the register.
- Reviewing patients flagged as on a register without supporting evidence, so the register reflects reality.
- Cross-checking registers against repeat medication and the clinical record; a medicine alone does not confirm a diagnosis or justify adding a patient to a register.
- Cleaning up duplicate or legacy codes that confuse the QOF business rules.
This register work is unglamorous and easy to defer, which is precisely why it pays off. A clean register makes every downstream search and recall more accurate. Much of it draws on the same population searching used for broader medicines optimisation, so it does not sit in isolation from the rest of the medicines work.
Searches, recall and getting patients through the door
Once registers are sound, the next job is finding who still needs a review or a missing measurement, and getting them booked. Practices typically run searches in their clinical system to build call and recall lists, but the searches are only useful if someone acts on them every week and feeds back what they find.
A clinical pharmacist working inside the practice’s EMIS, SystmOne, Vision or Medicus instance can run those searches, prioritise patients sensibly, and turn lists into action. Rather than inviting everyone at once, the work can be staged: deal with the patients who need only a blood test or a blood pressure reading separately from those who need a full medication review. That keeps clinician appointments for the patients who genuinely need them and lets simpler gaps be closed efficiently.
Recall also benefits from continuity. When the same team runs the searches month after month, they learn which cohorts are hardest to reach and can plan around them, rather than discovering the problem in February. This kind of steady, system-based searching is closely related to the quality improvement and audit work pharmacists already do for practices, and it shares the same data discipline as clinical medication reviews.
Accurate coding: where points are won or quietly lost
You can do excellent clinical work and still lose QOF points if the outcome is not coded, or is coded in a way the business rules do not recognise. Coding is the step most often rushed, and it is where a lot of avoidable underachievement hides.
Pharmacists help by being exact about recording. That means coding the blood pressure reading, the review, the medication change and the patient’s decision, not just writing it in free text. It means using exception or personalised care adjustment codes appropriately, for patients who genuinely cannot or should not be treated to target, rather than as a catch-all. And it means understanding how the rules treat timing, so a review done in the right window actually counts.
Good coding has a benefit beyond QOF. The same accurate record supports safe prescribing, makes future reviews quicker, and stands up to scrutiny if the practice is inspected. CQC registration requirements depend on the regulated activities and delivery arrangements. Where work is delivered within a practice’s registered service, the practice retains its regulatory duties and the provider remains accountable for its own service. Pharmacists are regulated by the GPhC.
Newer priority areas: cardiovascular and obesity-related care
In the 2026/27 QOF, CHOL003 is worth 20 points, while DM034 and DM035 are worth 8 points each. Plan against the current indicators and clinical priorities rather than assuming that every cardiovascular measure has gained points.
For 2026/27, new indicators include CD001/CD002 for blood pressure in CHD, stroke or TIA; HF009 for four medicine groups in heart failure with reduced ejection fraction; DM037 for all eight diabetes care processes; and OB004/OB005 for eligible obesity-related care. Pharmacist input should follow the individual’s needs, the clinician’s competence and the agreed pathway.
On the cardiovascular side, pharmacists can work through patients with raised blood pressure or high cholesterol, optimise antihypertensives and lipid-lowering treatment, arrange the monitoring that should accompany those changes, and make sure the readings and decisions are recorded. They can also pick up patients who are eligible for treatment but have never been started, which is often where the biggest clinical gains sit.
OB004 concerns referral of eligible adults living with obesity to a weight-management programme within 90 days of recording BMI. OB005 applies to the NICE TA1026 funding-variation cohorts and requires a recorded shared decision-making discussion, an offer of NICE-approved medicines management for primary care and referral to suitable behavioural support within the preceding 12 months. A conversation alone does not meet the full indicator. Check the current NHS England QOF guidance for the complete eligibility, timing, exclusion and coding rules.
How a managed service keeps the cycle on track
The hardest part of QOF is not any single task. It is keeping all of these threads moving at once, every month, alongside everything else a practice has to do. This is where a managed clinical pharmacy service differs from simply having an extra pair of hands for a few weeks.
Virtual Pharmacist delivers a fully managed, remote clinical pharmacy service inside the practice’s own clinical system. We are accountable for the service we deliver, including its clinical governance, supervision and quality assurance, supported by GPhC-registered pharmacists and pharmacy technicians and a full information governance stack. For QOF, that means the searches, register cleaning, recall and coding are run to a consistent standard and coordinated across the year, not handled in isolated bursts.
A managed model also gives continuity. The same approach applies whether you are a single practice, a network coordinating activity across sites, or an ICB looking at variation between practices. The pharmacist and technician work is planned, supervised and quality-assured by us, which keeps the burden off your clinical team while the achievement work still gets done properly. You can read more about how this fits into wider clinical pharmacist support, how the technician role supports the same work through pharmacy technician support, and how we run governance and data security across all of it on our clinical governance and data security page.
Frequently asked questions
What does a QOF clinical pharmacist actually do day to day?
A clinical pharmacist working on QOF spends time running searches to find patients who need reviews or measurements, cleaning up disease registers, completing medication and monitoring reviews, and coding the outcomes accurately. The focus is on relevant current QOF indicators in cardiovascular, diabetes and respiratory care, alongside separate medicines-safety work. Searches, reviews and coding must follow the current indicator definitions.
Can clinical pharmacists improve QOF achievement on their own?
They contribute a great deal, but QOF is a practice-wide effort. Pharmacists are strongest on medicines-related indicators, register accuracy, recall and coding, and they free up GPs and nurses for the work only they can do. Achievement improves most when this activity is coordinated across the year rather than left to the final quarter, which is where a managed service helps.
How does accurate coding affect QOF income?
QOF rewards recorded, rule-compliant activity. Excellent clinical work that is not coded correctly, or is recorded only in free text, may not register against the relevant indicator. Careful coding of reviews, readings, medication changes and any appropriate exceptions makes sure the practice gets recognition for work it has genuinely done, and keeps the record accurate for clinical safety too.
Do clinical pharmacists help with cardiovascular and obesity priorities?
Yes, within their competence and the agreed pathway. Pharmacists can support appropriate cardiovascular medicines reviews and monitoring. For 2026/27, obesity-related QOF work includes OB004 referral and the full OB005 requirements for eligible patients: shared decision-making, an offer of medicines management and referral to behavioural support. Check the current NHS England guidance rather than treating a discussion or prescription alone as complete achievement.
Is Virtual Pharmacist providing staff to run our QOF work?
No. Virtual Pharmacist provides a managed clinical service, not staff. We deliver the searches, reviews, recall and coding remotely inside your clinical system, and we are accountable for that service, including its clinical governance, supervision and quality assurance. You get the achievement support without taking on supervision or employment responsibilities for the team doing it.
If your practice, PCN or ICB wants steadier QOF achievement with the searches, reviews, recall and coding coordinated across the year, we would be glad to talk it through. Contact Virtual Pharmacist to discuss what your QOF support could look like.
